Frequency of noncontiguous lymph node involvement in patients with resectable nonsmall cell lung carcinoma

Cancer

Volumn 86, Issue 7, 1999, Pages 1159-1164

  Bonner, James A ^a,b   Garces, Yolanda I ^a   Sawyer, Timothy E ^a   Gould, Perry M ^a   Foote, Robert L ^a   Deschamps, Claude ^a   Lange, Carla M ^a   Li, Hongzhe ^a  

^a MAYO CLINIC   (United States)

^b The University of Alabama at Birmingham   (United States)

Author keywords

Lymph nodes; Mediastinal neoplasms; Nonsmall cell lung carcinoma; Resection

Indexed keywords

ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDIASTINUM LYMPH NODE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MEDIASTINUM; SURVIVAL RATE;

EID: 0033215320     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991001)86:7<1159::AID-CNCR9>3.0.CO;2-K     Document Type: Article

References (26)

1. Martini N, Flehinger BJ, Zaman MB, Beattie EJ Jr. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. Ann Surg 1983;198: 386-97.
2. Goldstraw P, Mannam GC, Kaplan DK, Michail P. Surgical management of nonsmall cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). J Thorac Cardiovasc Surg 1994;107:19-27.
3. Watanabe Y, Hayashi Y, Shimizu J, Oda M, Iwa T. Mediastinal nodal involvement and the prognosis of nonsmall cell lung cancer. Chest 1991;100:422-8.
4. 0 disease. Br J Cancer 1996;74: 632-9.
5. Debevec M, Bitenc M, Vidmar S, Rott T, Orel J, Strojan P, et al. Postoperative radiotherapy for radically resected N2 nonsmallcell lung cancer (NSCLC): randomised clinical study, 1988-1992. Lung Cancer 1996;14:99-107.
6. Lee JD, Ginsberg RJ. The multimodality treatment of stage III A/B nonsmall cell lung cancer: the role of surgery, radiation, and chemotherapy. Hematol Oncol Clin North Am 1997;11:279-301.
7. Miller DL, McManus KG, Allen MS, Ilstrup DM, Deschamps C, Trastek VF, et al. Results of surgical resection in patients with N2 nonsmall cell lung cancer. Ann Thorac Surg 1994; 57:1095-100.
8. Vansteenkiste JF, De Leyn PR, Deneffe GJ, Stalpaert G, Nackaerts KL, Lerut TE, et al. Survival and prognostic factors in resected N2 nonsmall cell lung cancer: a study of 140 cases. Ann Thorac Surg 1997;63:144-150.
9. Sawyer TE, Bonner JA, Gould PM, Foote RL, Deschamps C, Trastek VF, et al. The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement. Cancer 1997;80:1399-408.
10. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978;76:832-9.
11. Armitage P, Berry G. Statistical methods in medical research. 3rd edition. Oxford: Blackwell Scientific Publications, 1994.
12. Kaplan EL, Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc 1958;53:457-81.
13. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
14. Garces YI, Bonner JA, Sawyer TE, Gould PM, Foote RL, Trastek VF, et al. The frequency of noncontiguous lymph node involvement in patients with resectable nonsmall cell lung cancer [abstract]. Int J Radiat Oncol Biol Phys 1997; 39(Suppl):317.
15. Izbicki JR, Thetter O, Habekost M, Karg O, Passlick B, Kubuschok B, et al. Radical systematic mediastinal lymphadenectomy in nonsmall cell lung cancer: a randomized controlled trial. Br J Surg 1994;81:229-35.
16. Sawyer TE, Bonner JA, Gould PM, Foote RL, Deschamps C, Trastek VF, et al. Effectiveness of postoperative irradiation in stage IIIA nonsmall cell lung cancer according to regression tree analyses of recurrence risks. Ann Thorac Surg 1997;64:1402-8.
17. Steinert HC, Hauser M, Allemann F, Engel H, Berthold T, von Schulthess GK, et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997;202: 441-6.
18. Krasna MJ. Role of thoracoscopic lymph node staging for lung and esophageal cancer. Oncology (Huntingt) 1996;10: 793-802.
19. Passlick B, Izbicki JR, Kubuschok B, Thetter O, Pantel K. Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis. Ann Thorac Surg 1996;61: 177-82.
20. Akamatsu H, Terashima M, Koike T, Takizawa T, Kurita Y. Staging of primary lung cancer by computed tomography-guided percutaneous needle cytology of mediastinal lymph nodes. Ann Thorac Surg 1996;62:352-5.
21. Protopapas Z, Westcott JL. Transthoracic needle biopsy of mediastinal lymph nodes for staging lung and other cancers. Radiology 1996;199:489-96.
22. Shimoyama K, Murata K, Takahashi M, Morita R. Pulmonary hilar lymph node metastases from lung cancer: evaluation based on morphology at thinsection, incremental, dynamic CT. Radiology 1997;203:187-95.
23. Ginsberg RJ. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas. J Thorac Cardiovasc Surg 1996;111: 1123-4.
24. Riquet M, Hidden G, Debesse B. Direct lymphatic drainage of lung segments to the mediastinal nodes: an anatomic study on 260 adults. J Thorac Cardiovasc Surg 1989;97:623-32.
25. Tateishi M, Fukuyama Y, Hamatake M, Kohdono S, Ishida T, Sugimachi K. Skip mediastinal lymph node metastasis in nonsmall cell lung cancer. J Surg Oncol 1994;57:139-42.
26. Yoshino I, Yokoyama H, Yano T, Ueda T, Takai E, Mizutani K, et al. Skip metastasis to the mediastinal lymph nodes in nonsmall cell lung cancer. Ann Thorac Surg 1996;62:1021-5.